Sunniva (CSE: SNN) (OTCQX: SNNVF) was recently covered in a publication by Beacon Securities Limited that argued that Sunniva is significantly undervalued. An article further discussing the company reads: “Cannabis supplier Sunniva Inc.’s (CSE: SNN) (OTCQX: SNNVF) strengthening foothold in California’s and Canada’s consumer-populated markets has been failing to translate to its stock price and market cap since it began trading on the Canadian Securities Exchange and the U.S. OTCQX® Best Market in January, leading investment researchers at Beacon Securities Limited (http://ibn.fm/K5a88) to classify Sunniva’s public offering as a “badly mispriced” listing that could reward investors who buy in at undervalued levels reported at the time of its July 30 market update, titled ‘Sunniva Inc. (CSE: SNN) California Dreams Have Never Been This Cheap’. …Beacon Securities argues that Sunniva’s assets in Canada are worth more than the company’s entire current $180 million market cap and that its near-commercialization property in California is effectively being given zero value, ‘or, in fact, negative — a proposition that is ludicrous given the imminent launch of its 489,000 SF greenhouse (with on-site dispensary and distribution license) in the world’s largest cannabis market in California.’”
To view the full article, visit http://ibn.fm/TxRje
About Sunniva Inc.
Sunniva, through its subsidiaries, is a vertically integrated cannabis company operating in the world’s two largest cannabis markets – Canada and California – where it is committed to delivering safe, high-quality products and services at scale and creating trusted Sunniva branded cannabis products. The company’s vision is to become one of the lowest cost, highest quality vertically integrated cannabis producers in the markets it serves by building large scale purpose-built current cGMP designed greenhouses and expansion of retail locations, offering better quality assurance with cannabis products free from pesticides, providing better customer access to cannabis education and sourcing better therapeutic delivery devices. Sunniva’s management and board of directors have a proven track record for creating significant shareholder value both in the healthcare and biotech industries. For more information, visit the company’s website at www.Sunniva.com
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
